257 related articles for article (PubMed ID: 24469382)
21. EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients.
Einhäupl K; Stam J; Bousser MG; De Bruijn SF; Ferro JM; Martinelli I; Masuhr F;
Eur J Neurol; 2010 Oct; 17(10):1229-35. PubMed ID: 20402748
[TBL] [Abstract][Full Text] [Related]
22. Effect of recanalization on clinical outcomes in patients with cerebral venous thrombosis - An ambispective study.
Karthik Vanukuri N; Pedapati R; Shanmugam S; Hazeena P; Rangasami R; Venkatasubramanian S
Eur J Radiol; 2022 Aug; 153():110385. PubMed ID: 35661457
[TBL] [Abstract][Full Text] [Related]
23. Cerebral venous sinus Thrombosis: Clinical Features, Long-Term outcome and recanalization.
Gazioglu S; Eyuboglu I; Yildirim A; Aydin CO; Alioglu Z
J Clin Neurosci; 2017 Nov; 45():248-251. PubMed ID: 28802797
[TBL] [Abstract][Full Text] [Related]
24. Predictors of hospital outcome in patients with cerebral venous thrombosis.
Korathanakhun P; Sathirapanya P; Geater SL; Petpichetchian W
J Stroke Cerebrovasc Dis; 2014; 23(10):2725-2729. PubMed ID: 25307433
[TBL] [Abstract][Full Text] [Related]
25. Severe Cerebral Venous and Sinus Thrombosis: Clinical Course, Imaging Correlates, and Prognosis.
Kowoll CM; Kaminski J; Weiß V; Bösel J; Dietrich W; Jüttler E; Flechsenhar J; Guenther A; Huttner HB; Niesen WD; Pfefferkorn T; Schirotzek I; Schneider H; Liebig T; Dohmen C
Neurocrit Care; 2016 Dec; 25(3):392-399. PubMed ID: 27000641
[TBL] [Abstract][Full Text] [Related]
26. An Observational Study to Evaluate the Effectiveness of Rivaroxaban in the Management of Cerebral Venous Sinus Thrombosis.
Fatima M; Asghar MS; Abbas S; Iltaf S; Ali A
Cureus; 2021 Mar; 13(3):e13663. PubMed ID: 33824814
[TBL] [Abstract][Full Text] [Related]
27. Thrombosis of the Cerebral Veins and Sinuses in Hamadan, West of Iran.
Ghiasian M; Mansour M; Mazaheri S; Pirdehghan A
J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1313-9. PubMed ID: 26987492
[TBL] [Abstract][Full Text] [Related]
28. Cerebral venous congestion as indication for thrombolytic treatment.
Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
[TBL] [Abstract][Full Text] [Related]
29. A Study of Cerebral Venous Sinus Thrombosis with Special Reference to Newer Risk Predictors.
Khambholja J; Panchal SS; Gami JI
J Assoc Physicians India; 2024 May; 72(5):45-56. PubMed ID: 38881110
[TBL] [Abstract][Full Text] [Related]
30. Cerebral venous sinus thrombosis: review of cases in a single centre in Malaysia.
Sim SK; Tan YC; Ghani ARI
Med J Malaysia; 2020 Jan; 75(1):38-42. PubMed ID: 32008018
[TBL] [Abstract][Full Text] [Related]
31. Lower lymphocyte to monocyte ratio is a potential predictor of poor outcome in patients with cerebral venous sinus thrombosis.
Li S; Liu K; Zhang R; Gao Y; Fang H; Liu X; Pei L; Chou LR; Guan S; Guo X; Xu H; Song B; Xu Y
Stroke Vasc Neurol; 2019 Sep; 4(3):148-153. PubMed ID: 31709121
[TBL] [Abstract][Full Text] [Related]
32. Outcome of heparin-treated patients with acute cerebral venous sinus thrombosis: influence of the temporal pattern of intracerebral haemorrhage.
Busch MA; Hoffmann O; Einhäupl KM; Masuhr F
Eur J Neurol; 2016 Sep; 23(9):1387-92. PubMed ID: 27297773
[TBL] [Abstract][Full Text] [Related]
33. Cerebral Venous Sinus Thromboses in Patients with SARS-CoV-2 Infection: Three Cases and a Review of the Literature.
Nwajei F; Anand P; Abdalkader M; Andreu Arasa VC; Aparicio HJ; Behbahani S; Curiale G; Daneshmand A; Dasenbrock H; Mayo T; Mian A; Nguyen T; Ong C; Romero JR; Sakai O; Takahashi C; Cervantes-Arslanian AM
J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105412. PubMed ID: 33254367
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of systemic immune-inflammation index in acute/subacute patients with cerebral venous sinus thrombosis.
Li S; Liu K; Gao Y; Zhao L; Zhang R; Fang H; Tao Y; Liu H; Zhao J; Xia Z; Xu Y; Song B
Stroke Vasc Neurol; 2020 Dec; 5(4):368-373. PubMed ID: 32586971
[TBL] [Abstract][Full Text] [Related]
35. [The clinical characteristics of neutrophil extracellular trap in patients with severe cerebral venous sinus thrombosis and its prognostic value in acute and subacute patients].
Wang W; Jia Q; Wang SB; Li XD; Fan YM
Zhonghua Wai Ke Za Zhi; 2024 May; 62(5):443-451. PubMed ID: 38548615
[No Abstract] [Full Text] [Related]
36. Cerebral Venous Sinus Thrombosis in COVID-19 Patients: A Multicenter Study and Review of Literature.
Abdalkader M; Shaikh SP; Siegler JE; Cervantes-Arslanian AM; Tiu C; Radu RA; Tiu VE; Jillella DV; Mansour OY; Vera V; Chamorro Á; Blasco J; López A; Farooqui M; Thau L; Smith A; Gutierrez SO; Nguyen TN; Jovin TG
J Stroke Cerebrovasc Dis; 2021 Jun; 30(6):105733. PubMed ID: 33743411
[TBL] [Abstract][Full Text] [Related]
37. Risk factors governing the development of cerebral vein and dural sinus thrombosis after craniotomy in patients with intracranial tumors.
Gessler F; Bruder M; Duetzmann S; Tritt S; Bernstock JD; Seifert V; Senft C
J Neurosurg; 2018 Feb; 128(2):373-379. PubMed ID: 28387630
[TBL] [Abstract][Full Text] [Related]
38. Factors influencing therapy choice and clinical outcome in cerebral venous sinus thrombosis.
Krajíčková D; Král J; Herzig R; Klzo Ľ; Krajina A; Havelka J; Šimůnek L; Vyšata O; Van Quang T; Bar M; Vališ M
Sci Rep; 2020 Dec; 10(1):21633. PubMed ID: 33303787
[TBL] [Abstract][Full Text] [Related]
39. Pattern of magnetic resonance imaging and magnetic resonance venography changes in cerebral venous sinus thrombosis.
Zafar A; Ali Z
J Ayub Med Coll Abbottabad; 2012; 24(1):63-7. PubMed ID: 23855098
[TBL] [Abstract][Full Text] [Related]
40. Endovascular treatment for vaccine-induced cerebral venous sinus thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccination: a report of three cases.
Cleaver J; Ibitoye R; Morrison H; Flood R; Crewdson K; Marsh A; Abhinav K; Bosnell R; Crossley R; Mortimer A
J Neurointerv Surg; 2022 Sep; 14(9):853-857. PubMed ID: 34782400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
